Administrative/Regulatory,
Health Care & Hospital Law
Aug. 24, 2023
Fifth Circuit medication abortion ruling could affect more than abortion access
The case threatens the FDA’s regulatory authority and could lead to established, safe medications being challenged simply because they are politically contentious.
Cathren Cohen
Staff Attorney
UCLA Law Center
Reproductive, Health, Law, and Policy
Email: cohenc@law.ucla.edu
Abortion medication has become crucial to access in a post-Dobbs landscape, where more than half of U.S. states have or are expected to ban or severely restrict abortion rights. Even before Roe was overturned, medication abortions made up more than half of abortions in the U.S. Since
Or access this article for $45
Already a subscriber?
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Sign In
Enewsletter Sign-up